Synthekine

Verified by our team

  • Research
Linkedin Twitter Facebook

Synthekine is a biotechnology company developing selective cytokine therapeutics to treat cancer and autoimmune diseases. By leveraging immunological insights and targeted protein engineering, Synthekine designs safe and effective treatments with promising preclinical results.

Synthekine Highlights:

  • Synthekine annual revenue is $4.5M.
  • Synthekine total funding is $289.5M.
  • Synthekine headquartered in Menlo Park, California.
  • Synthekine number of employees is 110.

    • Overview

    • Website: synthekine.com
    • Headquarters: Menlo Park, California
    • Employees: 110
    • Founded: 2018
    • Email: pjaspuria@synthekine.com
    • Funding: $289.5M
    • Revenue: $4.5M
    • Valuation: n/a

    Contacts

    Patrick Lupardus

    President
    Linkedin
    • Email: ***@synthekine.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Synthekine

    Synthekine is located in Menlo Park, California.
    Yes, Synthekine is a Silicon Valley company.
    Synthekine total funding is 289.5M.
    Synthekine revenue is 4.5M.
    Synthekine’s number of employees is 110.
    Synthekine’s CEO name is Patrick Lupardus.
    Synthekine was founded in 2018.
    Synthekine’s contact email is pjaspuria@synthekine.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ